These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1825435)

  • 1. Antiproliferative effects of lipoxygenase inhibitors on human leukemia cells.
    Snyder DS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():921-4. PubMed ID: 1825435
    [No Abstract]   [Full Text] [Related]  

  • 2. A Calluna vulgaris extract 5-lipoxygenase inhibitor shows potent antiproliferative effects on human leukemia HL-60 cells.
    Najid A; Simon A; Delage C; Chulia AJ; Rigaud M
    Eicosanoids; 1992; 5(1):45-51. PubMed ID: 1419080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines.
    Ayyub Khan M; Tateson JE; Hoffbrand AV; Wickremasinghe RG
    Leuk Res; 1993 Mar; 17(3):241-5. PubMed ID: 8450672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines.
    Snyder DS; Castro R; Desforges JF
    Exp Hematol; 1989 Jan; 17(1):6-9. PubMed ID: 2908862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human cancer cell proliferation by lipoxygenase inhibitors and gamma-radiation in vitro.
    Hofmanová J; Musilová E; Kozubík A
    Gen Physiol Biophys; 1996 Aug; 15(4):317-31. PubMed ID: 9088929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
    Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP
    J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of antileukaemic drugs.
    Brusamolino E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphologic changes of apoptosis induced in human chronic myelogenous leukemia "blast" cells by SC41661A (Searle), a selective inhibitor of 5-lipoxygenase.
    Anderson KM; Seed TM; Peng J; Jajeh A; Meng J; Harris JE
    Scanning Microsc; 1994; 8(3):675-84; discussion 684-6. PubMed ID: 7747166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative effect of coumarins on several cancer cell lines.
    Kawaii S; Tomono Y; Ogawa K; Sugiura M; Yano M; Yoshizawa Y
    Anticancer Res; 2001; 21(2A):917-23. PubMed ID: 11396185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines.
    Tsukada T; Nakashima K; Shirakawa S
    Biochem Biophys Res Commun; 1986 Nov; 140(3):832-6. PubMed ID: 3778487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
    McGuire JJ; Magee KJ; Russell CA; Canestrari JM
    Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxygenase inhibitors suppress proliferation of G5:113 fibrosarcoma cells in vitro but they have no anticancer activity in vivo.
    Hoferová Z; Fedorocko P; Hofer M; Hofmanová J; Kozubík A; Eliásová V
    Neoplasma; 2003; 50(2):102-9. PubMed ID: 12740643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro.
    Miller AM; Kobb SM; McTiernan R
    Cancer Res; 1990 Nov; 50(22):7257-60. PubMed ID: 2121333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
    McGuffie EM; Pacheco D; Carbone GM; Catapano CV
    Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
    Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
    Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipoxygenation in human natural killer cell activation.
    Bray RA; Brahmi Z
    J Immunol; 1986 Mar; 136(5):1783-90. PubMed ID: 3081633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the biopreparation Lymphotilin as an antiproliferative and antitumor agent].
    Tiagotin IuV; Polotskiĭ AE; Vakhitov TIa; Tutova IIu; Rybakova LP
    Vopr Onkol; 1998; 44(1):92-6. PubMed ID: 9578739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
    Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxygenase inhibitors induce arrest of tumor cells in S-phase of the cell cycle.
    Hofmanová J; Soucek K; Pacherník J; Kovaríková M; Hoferová Z; Minksová K; Netíková J; Kozubík A
    Neoplasma; 2002; 49(6):362-7. PubMed ID: 12584583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.